Delivery Order SPE2DR25D2211-SPE2DR26FM7C8
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,605.63 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5 gram packages on August 22, 2025, with completion expected by August 25, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle. The pharmaceutical product will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $1,344.52 delivery order to AmerisourceBergen Drug Corp for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This firm fixed-price delivery order, issued on August 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $1,296.00 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with an ultimate completion date of December 8, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,183.65 to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Testosterone 1% (25mg/2.5g) in unit dose packaging. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 25, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the open competitive procurement process....
- The Defense Logistics Agency awarded a delivery order valued at $1,296.00 to AmerisourceBergen Drug Corp for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This is a firm fixed-price delivery order with an ultimate completion date of October 27, 2025, and was competitively awarded without set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate office and serves as...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,633.36 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This contract was competitively awarded with no set-aside designation and employs firm fixed pricing. The delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $1,941.66 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency has awarded a delivery order valued at $1,296.00 to AmerisourceBergen Drug Corp for testosterone 1% (25mg/2.5g) in 2.5-gram packets. This is a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for testosterone 1% (25mg/2.5g) in 2.5-gram packages, with a ceiling value of $1,172.78. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and is classified as a child order under a larger contract vehicle. The product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of April 25, 2025....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This firm fixed-price delivery order, valued at $1,796.23, represents a non-set-aside competitive award with an ultimate completion date of July 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the contract at its corporate office location. This award is issued as a child...
- SPE2DR25D2211Indefinite Delivery Contract
- SPE2DR25D2211-SPE2DR26FM7C8Delivery Order
The Defense Logistics Agency (DLA) awarded a $1,258.74 delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) pharmaceutical supplies, with an ultimate completion date of December 18, 2025. This firm fixed-price contract represents a child delivery order issued under a larger indefinite delivery contract vehicle and was competitively awarded without set-aside designation. The contractor will perform at its corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's comprehensive $999.99 billion indefinite delivery contract with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as the primary pharmaceutical supply vehicle for military healthcare systems worldwide. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp supplies critical medications and medical commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's federal contract portfolio demonstrates its extensive capability to fulfill diverse pharmaceutical procurement requirements, ranging from routine medication orders to specialized medical supplies supporting global military operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 12/16/25 |